The Contribution of Socioeconomic Factors to HIV RNA Suppression in Persons With HIV Engaged in Care in the NA-ACCORD

J Acquir Immune Defic Syndr. 2024 Nov 1;97(3):232-241. doi: 10.1097/QAI.0000000000003486.

Abstract

Introduction: Socioeconomic status (SES) influences well-being among people living with HIV (people with HIV [PWH]); when individual-level SES information is not available, area-level SES indicators may be a suitable alternative. We hypothesized that (1) select ZIP code-level SES indicators would be associated with viral suppression and (2) accounting for ZIP code-level SES would attenuate racial disparities in viral suppression among PWH.

Setting: The NA-ACCORD, a collaboration of clinical and interval cohorts of PWH, was used.

Methods: Participants with ≥1 viral load measurement and ≥1 US residential 5-digit ZIP code(s) between 2010 and 2018 were included. In this serial cross-sectional analysis, multivariable logistic regression models were used to quantify the annual association of race and ethnicity with viral suppression, in the presence of SES indicators and sex, hepatitis C status, and age.

Results: We observed a dose-response relationship between SES factors and viral suppression. Lower income and education were associated with 0.5-0.7-fold annual decreases in odds of viral suppression. We observed racial disparities of approximately 40% decreased odds of viral suppression among non-Hispanic Black compared with non-Hispanic White participants. The disparity persisted but narrowed by 3%-4% when including SES in the models.

Conclusions: ZIP code-based SES was associated with viral suppression, and accounting for SES narrowed racial disparities in viral suppression among PWH in the NA-ACCORD. Inclusion of ZIP code-level indicators of SES as surrogates for individual-level SES should be considered to improve our understanding of the impact of social determinants of health and racial disparities on key outcomes among PWH in North America.

MeSH terms

  • Adult
  • Anti-HIV Agents / therapeutic use
  • Cross-Sectional Studies
  • Female
  • HIV Infections* / drug therapy
  • Humans
  • Male
  • Middle Aged
  • RNA, Viral* / blood
  • Socioeconomic Factors*
  • United States
  • Viral Load*

Substances

  • RNA, Viral
  • Anti-HIV Agents

Grants and funding